Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Applications
- microbiota for Clinical Studies
- Drug Dolution for Liver Metastases
- Drug Dolution for Gastric Cancer
- Actionable Molecular Diagnostic System for Physicians
- Nuclear Medicine for Therapy
- Nuclear Medicine for Theragnostics
- Liposomes - Hollow Nanospheres for Gene Therapy
- Liposomes - Hollow Nanospheres for Cancer Therapy
- Liposomes - Hollow Nanospheres for Ocular Drug Delivery
- Liposomes - Hollow Nanospheres for Brain Drug Delivery
- Liposomes - Hollow Nanospheres for Vaccines
- Liposomes - Hollow Nanospheres for Immunomodulating Response
- Liposomes - Hollow Nanospheres for Tissue Engineering
- Exosomes - Extracellular Vesicles for Validation and Quality Control
- Exosomes - Extracellular Vesicles for Cancer Treatment
- Exosomes - Extracellular Vesicles for Immunomodulating Response
- Exosomes - Extracellular Vesicles for Molecular Therapy
- Exosomes - Extracellular Vesicles for Brain Drug Delivery
- Exosomes - Extracellular Vesicles for Ocular Drug Delivery
Cancer Systemic Therapy Equipment Supplied In Europe
112 equipment items found
Manufactured by:Emosis Diagnostics SAS based inIllkirch-Graffenstaden, FRANCE
Primary aim is in assessing procoagulant states associated with cancer and cancer therapies, to inform physician’s decision making on initiating, pursuing or stopping anticoagulant prophylaxis in cancer patient. ...
by:Edinburgh Molecular Imaging based inEdinburgh, UNITED KINGDOM
Edinburgh Molecular Imaging has a portfolio of agents designed to improve detection and treatment of Cancer. All Agents progressed to date have been found to be safe, specific, sensitive and ...
Manufactured by:Curasight based inKøbenhavn N, DENMARK
Curasight has developed a novel and innovative Theranostics platform for improved cancer diagnose and treatment. The combination of using targeted radionuclide therapy to treat cancer, and a non-invasive PET imaging for diagnosing and monitoring, is known as Theranostics (Therapy + Diagnostics = Theranostics). Curasight’s solution combines the technologies uTREAT® (targeted radionuclide ...
by:IBA based inLouvain-La-Neuve, BELGIUM
Proteus®PLUS is a unique proton therapy solution for leading cancer centers striving to meet a large and growing patient base's treatment needs while further advancing your clinical reputation in cancer care. Its cutting-edge features can be configured into a tailored solution to meet your research, clinical, and business objectives. Proteus®PLUS is inspired by clinical excellence with ...
by:Edinburgh Molecular Imaging based inEdinburgh, UNITED KINGDOM
Edinburgh Molecular Imaging has a portfolio of agents designed to improve detection and treatment of Cancer. All Agents progressed to date have been found to be safe, specific, sensitive and ...
Manufactured by:Bioprojet based inParis, FRANCE
Oral follow-up treatment of injectable therapy for malignant hypercalcaemia, Palliative treatment of osteolysis of malignant origin with or without hypercalcaemia, in conjunction with specific cancer treatment, In the event of hypercalcaemia, the treatment must be associated with optimal rehydration. ...
Manufactured by:Vivesto AB based inSolna, SWEDEN
XR-18 is a research effort based on the XR-17 technology platform intended to provide enhanced properties that improve clinical formulations and applications of active pharmaceutical ingredients (APIs) for cancer treatment. This effort has recently generated promising data including: Addition of components to existing XR-17 formulation improving certain properties. Synthesis of novel excipients ...
Manufactured by:AJ Vaccines A/S based inKøbenhavn, DENMARK
VesiCulture (BCG Culture) For the treatment of Bladder ...
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
Recombinant human monoclonal antibody expressed in CHO binding to human ANGPT2. Anti-ANGPT2 Therapeutic Antibody is a monoclonal antibody designed for the treatment of ...
Manufactured by:Takeda Pharmaceutical Company Limited based inChuo-ku, JAPAN
Bortezomib (brand name: Velcade) is a treatment for multiple myeloma (a cancer of the plasma cells) and mantle cell lymphoma (a cancer of the lymph ...
Manufactured by:Vivesto AB based inSolna, SWEDEN
Apealea (paclitaxel micellar) is a patented solvent-free formulation: it applies paclitaxel – a cornerstone within chemotherapy for many different forms of cancer – through Vivesto’s XR-17 technology platform. Apealea is approved by the European regulatory authority EMA for use in combination with carboplatin for the treatment of adult patients with first relapse of ...
Manufactured by:Affimed GmbH based inHeidelberg, GERMANY
The proprietary ROCK platform enables a tumor-targeted approach that can be tailored across hematological and solid tumors. The ROCK (Redirected Optimized Cell Killing) platform allows for a modular approach to generating customizable ICE (innate cell engager) molecules. High-affinity ICE (innate cell engager) molecules, which are created using the ROCK platform, are capable of bivalent NK-cell ...
Manufactured by:Ernst Kratz GmbH based inBerlin, GERMANY
Especially in medical technology innovation is a warranty for future success. Acufirm is your reliable partner by implementing your ideas and special requests with precision and technical know how. Canulas, wires and tube sections for medical devices made from stainless steel or titanium which are used for cancer treatment, CT or endoscopy e.g. can be produced upon request in all variations. In ...
Manufactured by:EnteroBiotix Ltd based inGlasgow, UNITED KINGDOM
Both inside and out, the human body harbours ecosystems of micro-organisms, including bacteria, viruses, fungi and archaea. These microorganisms, their genomic potential and their collective repertoire of activity are known as ‘the ...
Manufactured by:The Menarini Group based inFlorence, ITALY
Elacestrant is a selective estrogen receptor degrader (SERD) evaluated for potential use as a once daily oral treatment in patients with estrogen receptor positive (ER+)/HER2- advanced or metastatic breast cancer. Studies completed to date, including the positive results from the EMERALD phase 3 trial, indicate that the compound has the potential for use as a single agent or in combination with ...
Manufactured by:Santa Cruz Biotechnology, Inc. based inDallas, TEXAS (USA)
Pheophorbide a is a chlorophyll-related compound studied for its anti-tumor and anti-cancer ...
by:IBA based inLouvain-La-Neuve, BELGIUM
Proteus® has been inspired by everyday clinical practice. Through day-to-day interactions with the community, IBA is perfectly positioned to understand, and invest in, the user’s needs. These investments are directly translated into benefits for the patients. The Proteus® design enhances the patient experience by fostering a soothing environment while making the medical ...
Manufactured by:Elekta Instrument AB based inStockholm, SWEDEN
Flexibility redefined, truly multifunctional: As the role of radiation therapy in cancer care grows, clinics need to offer a wide range of techniques for different indications. Elekta Infinity is truly multifunctional. High-quality treatments powered by advanced technology provide the freedom to tailor your solution to your clinical ...
by:RaySearch Laboratories based inStockholm, SWEDEN
Machine learning and data-driven oncology represents a new era in healthcare. RayIntelligence® is an innovative cloud-based oncology analytics system that gives meaning to data, empowering cancer centers to reach new levels of personalized care through insights based on clinical data. ...
by:Debiopharm based inLausanne, SWITZERLAND
Oxaliplatin is a diaminocyclohexane (DACH) platin. It is the active substance of the branded Eloxatin®/Elplat®/Dacotin®/Dacplat®, which has dramatically changed the prognosis of colorectal cancer. In 1996, prior to the introduction of oxaliplatin, the standard of care for colorectal cancer was 5-fluorouracil (5-FU). Combination of oxaliplatin with 5-FU and leucovorin (FOLFOX) ...